Vendor, Rockville, MD
Abvacc, Inc.
UEI K5MSGRFGVVZ9, CAGE 9FDC1
1 award and $21,963 obligated between February 28, 2024 and July 16, 2025, 100% under full and open competition, against 23.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $21,963 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93021C00021Definitive Contract, February 28, 2024, Full and Open Competition, 23 offers | National Institutes of Health NiaidNational Institutes of Health | To Develop a Potent Therapeutic Marburgvirus Monoclonal Antibody.NAICS 541715, PSC AN11 | $21,963 |
- Places of performance
- Maryland
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 4 across 1 awards